L-nucleoside enantiomers as antivirals drugs: a mini-review
- PMID: 16797735
- DOI: 10.1016/j.antiviral.2006.04.017
L-nucleoside enantiomers as antivirals drugs: a mini-review
Abstract
The discovery that some nucleoside analogues endowed with the unnatural L-configuration can possess biological activities has been a significant breakthrough in antiviral chemotherapy. In this regard, lamivudine (3TC) was the first L-nucleoside enantiomer approved against HIV and HBV, and several other L-nucleosides are currently under clinical development as antiviral agents.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
